182 related articles for article (PubMed ID: 32273643)
1. Temporal arteritis with focal pachymeningitis: a deceptive association.
Kutty RK; Maekawa M; Kawase T; Fujii N; Kato Y
Nagoya J Med Sci; 2020 Feb; 82(1):143-150. PubMed ID: 32273643
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic Pachymeningitis as a Potential Cause of Headache Associated with Temporal Arteritis.
Tokushige S; Matsuura H; Hideyama T; Tamura K; Maekawa R; Shiio Y
Intern Med; 2016; 55(5):523-6. PubMed ID: 26935376
[TBL] [Abstract][Full Text] [Related]
3. Focal hypertrophic pachymeningitis in association with temporal arteritis.
Kuhn J; Harzheim A; Brockmann M; Mahkorn D; Bewermeyer H
Headache; 2004; 44(10):1045-8. PubMed ID: 15546272
[TBL] [Abstract][Full Text] [Related]
4. Focal hypertrophic cranial pachymeningitis associated with temporal arteritis: a new case report.
Marano E; D'Armiento FP; Scarano V; Tortora F; Mignogna C; Briganti F
J Neurol; 2003 Jan; 250(1):98-100. PubMed ID: 12528001
[No Abstract] [Full Text] [Related]
5. Polymyalgia Rheumatica and Giant Cell Arteritis.
Buttgereit F; Matteson EL; Dejaco C
JAMA; 2020 Sep; 324(10):993-994. PubMed ID: 32897333
[No Abstract] [Full Text] [Related]
6. Optic Neuropathy with Headache and Palpable Temporal Arteries Due to Hypertrophic Pachymeningitis Rather than Giant Cell Arteritis.
Nakajima I; Taniguchi Y; Mizobuchi T; Kishimoto T; Fukushima A; Fukuda K
Ocul Immunol Inflamm; 2022 Aug; 30(6):1515-1518. PubMed ID: 33793376
[No Abstract] [Full Text] [Related]
7. Refractory Giant Cell Arteritis Complicated by Vision Loss From Optic Atrophy and Maculopathy Associated With Pachymeningitis.
Uribe JA; Aggarwal I; Witthayaweerasak J; Liao YJ; Berry GJ; Sab UK; Weyand CM
J Neuroophthalmol; 2018 Mar; 38(1):17-23. PubMed ID: 29059089
[TBL] [Abstract][Full Text] [Related]
8. Giant cell arteritis: beyond temporal artery biopsy and steroids.
Ninan JV; Lester S; Hill CL
Intern Med J; 2017 Nov; 47(11):1228-1240. PubMed ID: 28485026
[TBL] [Abstract][Full Text] [Related]
9. The Treatment of Giant Cell Arteritis in Different Clinical Settings.
Pfeil A; Oelzner P; Hellmann P
Front Immunol; 2018; 9():3129. PubMed ID: 30733723
[TBL] [Abstract][Full Text] [Related]
10. [Overlap syndrome of giant cell arteritis and pachymeningitis].
Kolb C; Müller M; Kohnen T
Ophthalmologie; 2022 Nov; 119(11):1149-1151. PubMed ID: 35089414
[No Abstract] [Full Text] [Related]
11. [Giant cell arteritis (cranial arteritis, temporal arteritis Horton)].
Schmidt D; Vaith P
Dtsch Med Wochenschr; 2005 Aug; 130(33):1877-81. PubMed ID: 16118731
[No Abstract] [Full Text] [Related]
12. Giant cell arteritis: new concepts, treatments and the unmet need that remains.
Coath F; Gillbert K; Griffiths B; Hall F; Kay L; Lanyon P; Luqmani R; Mackie SL; Mason JC; Mills J; Mollan S; Morgan AW; Mukhtyar C; Quick V; Watts R; Dasgupta B
Rheumatology (Oxford); 2019 Jul; 58(7):1123-1125. PubMed ID: 30423174
[No Abstract] [Full Text] [Related]
13. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?].
Samson M; Bonnotte B
Rev Med Interne; 2018 Feb; 39(2):75-77. PubMed ID: 29217104
[No Abstract] [Full Text] [Related]
14. Tocilizumab (Actemra) for giant cell arteritis.
Med Lett Drugs Ther; 2017 Sep; 59(1530):161-162. PubMed ID: 28922343
[No Abstract] [Full Text] [Related]
15. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
Camellino D; Matteson EL; Buttgereit F; Dejaco C
Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
Broner J; Arnaud E
Rev Med Interne; 2018 Feb; 39(2):78-83. PubMed ID: 29221884
[TBL] [Abstract][Full Text] [Related]
17. [Chronic idiopathic pachymeningitis associated with temporal arteritis. A case study].
Mateo O; Guardiola S; Esquinas G; Esteban J
Med Clin (Barc); 1996 Sep; 107(10):396-7. PubMed ID: 9036246
[No Abstract] [Full Text] [Related]
18. Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
Vionnet J; Buss G; Mayer C; Sokolov AA; Borruat FX; Spertini F
Joint Bone Spine; 2017 Oct; 84(5):615-619. PubMed ID: 28499892
[TBL] [Abstract][Full Text] [Related]
19. Refractory giant cell arteritis on prednisone and tocilizumab: improvement with subsequent tuberculosis reactivation.
Kherani I; Chin C; Kherani RB; Kherani F
Can J Ophthalmol; 2019 Aug; 54(4):e192-e194. PubMed ID: 31358167
[No Abstract] [Full Text] [Related]
20. Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases.
Font RL; Prabhakaran VC
Br J Ophthalmol; 2007 Feb; 91(2):204-9. PubMed ID: 16987903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
